1-3 of 3
Roberto Conte
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.

Antonio Curti, MD, Loredana Ruggeri, BS, Alessandra D’Addio, MD, Elena Urbani, BS, Andrea Bontadini, MD, Fiorenza Fruet, BS, Valeria Giudice, MD, Elisa Dan, BS, Maria Rosa Motta, BS, Simona Rizzi, BS, Stefania Paolini, MD, Gabriele Gugliotta, MD, Roberto Conte, MD, Giovanni Martinelli, MD, Andrea Velardi, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD
Journal: Blood
Blood (2007) 110 (11): 2857.
https://doi.org/10.1182/blood.V110.11.2857.2857
Published: 2007
Journal Articles

Phase II Study of a Single Pegfilgrastim Injection as Adjunct to Chemotherapy to Mobilize Stem Cells into Peripheral Blood of Resistant/Relapsed Lymphoma Patients.

Roberto M. Lemoli, MD, Alessandro Isidori, MD, Monica Tani, MD, Francesca Bonifazi, MD, Pier Luigi Zinzani, MD, Antonio Curti, MD, Maria Rosa Motta, BS, Simonetta Rizzi, BS, Valeria Giudice, MD, Oriana Farese, BS, Manuela Rovito, BS, Lapo Alinari, MD, Roberto Conte, MD, Michele Baccarani, MD
Journal: Blood
Blood (2004) 104 (11): 2871.
https://doi.org/10.1182/blood.V104.11.2871.2871
Published: 2004
Journal Articles

CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells

Maria Pia Pistillo, Pier Luigi Tazzari, Giulio Lelio Palmisano, Ivana Pierri, Andrea Bolognesi, Francesca Ferlito, Paolo Capanni, Letizia Polito, Marina Ratta, Stefano Pileri, Milena Piccioli, Giuseppe Basso, Laura Rissotto, Roberto Conte, Marco Gobbi, Fiorenzo Stirpe, Giovanni Battista Ferrara
Journal: Blood
Blood (2003) 101 (1): 202–209.
https://doi.org/10.1182/blood-2002-06-1668
Published: 2003